## MNST: Monster Beverage Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -3.3% below STRENGTH zone (4.0-10.0%); PEG 1.80 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($69.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. California Public Employees Retirement System Acquires 112,614 Shares of Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251209T102327 | Bullish | Relevance: 98%
- California Public Employees Retirement System increased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 9.3% in the second quarter, acquiring an additional 112,614 shares. The firm now owns 1,324,626 shares worth $82,975,000, representing 0.14% of the company's stock. Other institutional investors also adjusted their holdings in MNST, with several analysts maintaining "buy" ratings and an average target price of $71.45.

**2. The Zacks Analyst Blog Highlights Monster Beverage, MongoDB and Lumentum**
- Source: The Globe and Mail | 20251209T140827 | Bullish | Relevance: 98%
-  This Zacks Analyst Blog highlights Monster Beverage (MNST), MongoDB (MDB), and Lumentum (LITE), detailing their company profiles and market positions. It also provides a global economic outlook, discussing upcoming central bank meetings, particularly the U.S. Federal Reserve, and anticipates China's macro data while observing a potentially over-optimistic market sentiment for 2026. The article identifies these three stocks as "Zacks #1 Rank (STRONG BUY)" picks, offering detailed insights into their business segments, market capitalization, and Zacks scores for value, growth, and momentum.

**3. Natixis Acquires 73,249 Shares of Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251210T115243 | Bullish | Relevance: 97%
- Natixis increased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 122.8%, purchasing an additional 73,249 shares to own a total of 132,913 shares valued at approximately $8.33 million. This comes as Monster Beverage reported strong quarterly earnings, beating analyst expectations with $0.56 EPS and $2.20 billion in revenue, leading to an overall "Moderate Buy" analyst consensus for the stock. Insider Guy Carling, however, significantly reduced his ownership by selling 38,438 shares.

**4. Dave & Buster's (NASDAQ:PLAY) Misses Q3 CY2025 Revenue Estimates**
- Source: Finviz | 20251209T231008 | Neutral | Relevance: 62%
-  Dave & Buster's (NASDAQ:PLAY) reported Q3 CY2025 revenue of $448.2 million, missing analyst estimates by 2.8% with a 1.1% year-on-year decline. The company also posted a non-GAAP loss of $1.14 per share, 9.3% below expectations, and experienced a 4% decline in same-store sales. This softer quarter led to a 4.6% drop in stock price immediately following the announcement, highlighting concerns about its financial performance despite management's "back-to-basics" plan.

**5. Does Coca-Colaâ€™s Current Price Reflect Its Cash Flow Strength and Growth Outlook in 2025?**
- Source: Simply Wall Street | 20251210T023332 | Neutral | Relevance: 60%
-  An analysis of Coca-Cola's valuation reveals different perspectives. A Discounted Cash Flow (DCF) model suggests Coca-Cola is undervalued by 22% at an intrinsic value of $89.90 per share. However, when assessed using the Price to Earnings (PE) ratio, the stock appears to be priced about right, trading at 23.1x, which aligns with its fundamentals, although above the industry average but below its listed peers.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | Piper Sandler | $85 | $75 | +13% |
| 2025-12-03 | Wells Fargo | $83 | $75 | +11% |
| 2025-12-03 | BMO Capital | $73 | $53 | +38% |
| 2025-12-01 | RBC Capital | $81 | $75 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | Piper Sandler | main | Overweight |
| 2025-12-03 | Wells Fargo | main | Overweight |
| 2025-12-03 | BMO Capital | main | Market Perform |
| 2025-12-01 | RBC Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.74M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 6.9% (+3.2%)
- Blackrock Inc.: 6.1% (+3.7%)
- State Street Corpora: 3.9% (+8.0%)
- Alliancebernstein L.: 3.1% (-13.5%)
- LOOMIS SAYLES & CO L: 2.8% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +16%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.80 elevated, pricing in significant growth expectations. Forward P/E 32.6x stretched relative to 13% growth. Quality metrics strong (ROE 26%, ROA 17%, margin 22%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.24). Analyst sentiment positive (5 raises, avg +16%). Insider buying signal ($0.7M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $70.8B |
| Beta | 0.48 |
| 52W Range | $45.70 - $76.28 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.80 |
| Forward P/E | 32.6 |
| Current P/E | 36.9 |
| YoY Growth | 13.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.0% to -3.3% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.3pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.15x) but short-term weakness (below SMA20). RSI neutral at 50.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.30% (CS: 21) | Weak |
| RSI_14 | 50.5 | Neutral |
| MACD Histogram | -0.31 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.145x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $72.49
- **Stop Loss:** $69.77 (3.8% risk)
- **Target:** $75.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 507
- **Position Value:** $36,752.43
- **Portfolio %:** 36.75%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-26 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.53 | +9.2% |
| 2025Q2 | $0.48 | $0.50 | +4.1% |
| 2025Q1 | $0.46 | $0.45 | -2.7% |
| 2024Q4 | $0.40 | $0.28 | -29.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*